Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

By N. Tang, Huan Bai, Xing Chen, Jiale Gong, Dengju Li, Ziyong Sun. Journal of Thrombosis and Haemostasis, 2020

3,406 citations recorded by the source corpus.

A relatively high mortality of severe coronavirus disease 2019 (COVID‐19) is worrying, and the application of heparin in COVID‐19 has been recommended by some expert consensus because of the risk of disseminated intravascular coagulation and venous thromboembolism. However, its efficacy remains to be validated.

Subfields: Infectious Diseases, Ophthalmology, Surgery

View Paper: https://www.semanticscholar.org/paper/df102150189397589ea2f68dadc1c9acb3a2750f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

  1. J. Levy
  2. Richard C. Becker

In Surgery

  1. M. Cushman
  2. Joshua A. Beckman
  3. M. Levi

Citations in the corpus